| (₹ crores) | Q2FY26 | Q1FY26 | Q2FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 803.00 | 758.00 | 818.00 | 5.9% | -1.8% |
Total Expenses | 712.00 | 770.00 | 827.00 | -7.5% | -13.9% |
Profit Before Tax | 91.00 | -109.00 | -9.00 | -183.5% | -1111.1% |
Tax | 9.00 | -1.00 | 7.00 | -1000.0% | 28.6% |
Profit After Tax | 82.00 | -108.00 | -16.00 | -175.9% | -612.5% |
Earnings Per Share | 4.81 | -5.33 | -1.47 | -190.2% | -427.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Wockhardt Ltd is a global pharmaceutical and biotechnology company headquartered in India. It specializes in the manufacture and marketing of pharmaceutical and biopharmaceutical formulations. The company operates in the healthcare sector, focusing primarily on developing and producing generic drugs and innovative biopharmaceutical products. Wockhardt also has a significant presence in the antibiotics market and is involved in various therapeutic areas, including cardiology, dermatology, gastrointestinal, and respiratory. While the company has been actively participating in the pharmaceutical sector, detailed information on recent major developments is not available.
For the quarter ended Q2FY26, Wockhardt Ltd reported a total income of ₹803 crore. This represents a 5.9% increase compared to the previous quarter (Q1FY26), where the total income was ₹758 crore. However, when compared to the same quarter in the previous year (Q2FY25), there is a slight decrease of 1.8%, as the total income then was ₹818 crore. This data indicates a slight fluctuation in revenue over the year, with a noticeable quarter-on-quarter improvement.
In terms of profitability, Wockhardt Ltd showed a significant turnaround in Q2FY26 with a profit before tax of ₹91 crore. This is a remarkable improvement from the loss before tax of ₹109 crore recorded in Q1FY26 and a loss of ₹9 crore in Q2FY25. The profit after tax for Q2FY26 stood at ₹82 crore, a substantial improvement from the loss of ₹108 crore in the previous quarter and a loss of ₹16 crore in the same quarter last year. The earnings per share also reflected this positive change, with a value of ₹4.81 in Q2FY26, compared to negative values of ₹-5.33 in Q1FY26 and ₹-1.47 in Q2FY25.
The total expenses for Wockhardt Ltd in Q2FY26 were ₹712 crore, which is a decrease of 7.5% from the previous quarter's expenses of ₹770 crore. Compared to Q2FY25, there is a 13.9% reduction from the expenses of ₹827 crore. The tax expense in Q2FY26 was ₹9 crore, showing a notable increase from the tax credit of ₹-1 crore in Q1FY26 and a slight rise from ₹7 crore in Q2FY25. These figures underline a considerable improvement in the company's cost management and operational efficiency over the quarters.
Wockhardt Ltd announced its Q2 FY 2025-26 results on 10 November, 2025.
Wockhardt Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Wockhardt Ltd Q2 FY 2025-26 results include:
Wockhardt Ltd reported a net loss of ₹82.00 crore in Q2 FY 2025-26, reflecting a -612.5% year-over-year growth.
Wockhardt Ltd posted a revenue of ₹803.00 crore in Q2 FY 2025-26.